• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 2
  3. Authors

Online ISSN: 2515-8260

Volume7, Issue2

ROLE OF HOMOEOPATHY IN MANAGEMENT OF COVID-19 COMPLICATIONS

    Dr. Gaurav Gupta Dr. Hemant Vyas Dr. Ravi Jain Dr. Bharat , Sharma

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 2, Pages 1204-1212

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

First time on December 30, 2019, a report of a cluster of pneumonia of unknown aetiology
was published on ProMED-mail, possibly related to contact with a seafood market in Wuhan,
China. [1] Following this till October 15, 2020, 38,394,169 confirmed cases of COVID-19,
including 1,089,047 deaths have been reported to World Health Organization. [2]
First time, this case was reported on December 31, 2019 by WHO Country Office in China
but based on symptoms; its beginning can be traced in initial days of December 2019.
Initially for first few cases (n=29), this infection was classified as "pneumonia of unknown
etiology." Following intensive outbreak investigation by the Chinese Center for Disease
Control and Prevention (CDC) and local CDCs, this infection was classified as novel viral
infection belonging to the coronavirus (CoV) family. Finally on February 11, 2020, the WHO
Director-General, Dr. Tedros Adhanom Ghebreyesus, announced that the disease caused by
this new CoV was a "COVID-19," which is the acronym of "coronavirus disease 2019". [3]
This Coronaviruses are encapsulated, single-stranded RNA viruses that generally cause mild,
cold-like illnesses in human beings and belongs to SARS-coronavirus-2 (SARS-CoV-2). [4]
Keywords:
  • PDF (312 K)
  • XML
(2020). ROLE OF HOMOEOPATHY IN MANAGEMENT OF COVID-19 COMPLICATIONS. European Journal of Molecular & Clinical Medicine, 7(2), 1204-1212.
Dr. Gaurav Gupta; Dr. Hemant Vyas; Dr. Ravi Jain; Dr. Bharat , Sharma. "ROLE OF HOMOEOPATHY IN MANAGEMENT OF COVID-19 COMPLICATIONS". European Journal of Molecular & Clinical Medicine, 7, 2, 2020, 1204-1212.
(2020). 'ROLE OF HOMOEOPATHY IN MANAGEMENT OF COVID-19 COMPLICATIONS', European Journal of Molecular & Clinical Medicine, 7(2), pp. 1204-1212.
ROLE OF HOMOEOPATHY IN MANAGEMENT OF COVID-19 COMPLICATIONS. European Journal of Molecular & Clinical Medicine, 2020; 7(2): 1204-1212.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 1,598
  • PDF Download: 12,546
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus